July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Metabolomic- Genomic Association in Age-Related Macular Degeneration
Author Affiliations & Notes
  • Deeba Husain
    Retina Service/Opthal, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Yuan Qianyu
    School of public health, Harvard Univ, Boston, Massachusetts, United States
  • Ines Lains
    Retina Service/Opthal, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Wonil Chung
    School of public health, Harvard Univ, Boston, Massachusetts, United States
  • Rachel Kelly
    Channing Lab, Brigham and Women Hospital, Harvard Medical School, Boston, Massachusetts, United States
  • Rufino Silva
    Faculdadw de Medicina, Universidade de Coimbra, Coimbra, Portugal
  • John B Miller
    Retina Service/Opthal, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Demetrios Vavvas
    Retina Service/Opthal, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Ivana K Kim
    Retina Service/Opthal, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Jessica Lasky-Su
    Channing Lab, Brigham and Women Hospital, Harvard Medical School, Boston, Massachusetts, United States
  • Liming Liang
    School of public health, Harvard Univ, Boston, Massachusetts, United States
  • Joan W Miller
    Retina Service/Opthal, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Deeba Husain, Allergan (C), Commonwealth grant (F), Genetech (C); Yuan Qianyu, None; Ines Lains, None; Wonil Chung, None; Rachel Kelly, None; Rufino Silva, Alimera (C), allergan (C), Bayer (C), novartis (C), THEA (C); John Miller, Alcon (C), Allergan (C), Genetech (C), Heidelberg (C), Optovue (C), Zeiss (C); Demetrios Vavvas, None; Ivana Kim, Alcon/novartis (C), Bausch & lomb (C), Biophytsis (C), Castle biosciences (C); Jessica Lasky-Su, None; Liming Liang, None; Joan Miller, Bausch & Lomb (C), Genentech (C), Kavista (C), Lowry Medical Research (F), ONL (C), ONL (R), ONL therapeutics (P), Valeant (R), Valeant Pharma (P)
  • Footnotes
    Support  This study was financially supported by the Miller Retina Research Fund (Mass. Eye and Ear), the Champalimaud Vision Award (JWM), the unrestricted departmental Grant from Research to Prevent Blindness, Inc. New York, and the Portuguese Foundation for Science and Technology/ Harvard Medical School Portugal Program (HMSP-ICJ/006/2013). The commonwealth of Massachusetts grant. None of the aforementioned funding organizations had any role in the design or conduct of this research.
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 2212. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Deeba Husain, Yuan Qianyu, Ines Lains, Wonil Chung, Rachel Kelly, Rufino Silva, John B Miller, Demetrios Vavvas, Ivana K Kim, Jessica Lasky-Su, Liming Liang, Joan W Miller; Metabolomic- Genomic Association in Age-Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2019;60(9):2212.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Previous studies have identified genetic variants and metabolites associated with age-related macular degeneration (AMD), a multifactorial disease involving genetic and environmental risk factors. However, the interaction among these factors and how they promote AMD remains largely unknown. Metabolomic-genomic studies can provide unique insights to this end. This study aimed to analyze association between single nucleotide polymorphisms (SNPs) and metabolites in a multicenter cohort of AMD patients and controls.

Methods : Prospectively recruited, cross-sectional, multicenter study (Boston, United States and Coimbra, Portugal). We included 388 subjects with AMD (any stage of disease) and 98 controls without any vitreoretinal disease (age > 50 years). Color fundus photographs were used for AMD grading (AREDS classification scheme). Fasting blood samples were processed and analyzed using ultrahigh-performance liquid chromatography and high-resolution mass spectrometry (Metabolon, Inc.). Single nucleotide polymorphisms (SNP) were genotyped using an Illumina Omni express platform. Association between metabolites and AMD were tested using logistic regression and meta-analysis to combine the two populations. Analyses of metabolomic quantitative trait loci (mQTL) were conducted using linear regression models, adjusted for age, sex, and the 10 first principal components (PC) of both metabolites and SNPs. Benjamini–Hochberg procedures were used to account for false discovery rate (FDR) in all performed analysis.

Results : We first looked at the plasma metabolomic profiles of AMD patients as compared to controls and observed that, accounting for FDR and confounding, 28 metabolites differed significantly between them (FDR<0.05). Among these metabolites, half (n=14) were significantly associated with at least one SNP only in patients with AMD, and not controls (Table 1, p < 1.2e-7). These metabolites corresponded to 890 mQTL (metabolite-SNP pairs), and were mostly amino acids and lipids. N-acetyle asparagine showed the most significant association (690 mQTL).(Figure1)

Conclusions : To our knowledge, this is the first study on metabolomic-genomic associations in AMD. Our results suggest that mQTL SNPs are associated with AMD, thus providing a basis for further exploration. This has the potential to increase our understanding of the biological relevance of AMD-risk SNPs

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×